Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Methylergometrine (0.2mg)
Therapeutic Category
ENDOCRINOLOGY and Hormonal range, Gynecology and Fertility
Dosage Form
Injection
Packaging Type
Vial
Packaging
1ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Methezen 0.2 Injection contains Methylergometrine (0.2mg), a potent ergot alkaloid used primarily in obstetric care to manage and prevent postpartum hemorrhage (PPH) due to uterine atony. Uterine atony occurs when the uterus fails to contract effectively after childbirth, leading to excessive bleeding. Methylergometrine works by stimulating uterine muscles, helping the uterus contract and reduce blood loss. This medication plays a crucial role in emergency settings where rapid intervention is necessary to prevent life-threatening hemorrhage.
Methezen 0.2 Injection is most commonly administered by healthcare professionals immediately after delivery to control or prevent postpartum bleeding. It helps in stabilizing the mother's condition by promoting the constriction of blood vessels and reducing the volume of bleeding. Methylergometrine is considered a vital part of the standard care in managing obstetric bleeding complications.
In addition to its use in postpartum hemorrhage, Methylergometrine has some off-label uses in controlling bleeding caused by uterine fibroids or other gynecological procedures. However, its use is strictly monitored due to the possibility of serious side effects, especially with prolonged or inappropriate use.
May cause nausea, vomiting, dizziness, headache, increased blood pressure, abdominal cramps, or uterine hypertonia. Serious side effects like seizures or vasoconstriction are rare but possible.
Utilair 0.2 Injection is used for the prevention and treatment of postpartum hemorrhage due to uterine atony, promoting uterine contraction to control bleeding after childbirth.
Should only be used under the supervision of a healthcare professional. Not recommended for patients with hypertension or cardiovascular disease without doctor approval.
Store at room temperature, away from direct light and moisture. Keep the injection out of reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Methylergometrine 0.2 mg Injection is a uterotonic (oxytocic) injectable medicine used in obstetrics for the prevention and management of postpartum hemorrhage (PPH) and control of excessive uterine bleeding after childbirth or abortion. It increases uterine tone and contraction. It is a key gynecology and obstetric emergency injectable segment product, widely used in maternity hospitals, nursing homes, and delivery units under strict medical supervision.
Medical distributors and wholesalers can benefit from steady and essential demand from maternity hospitals, gynecologists, and emergency obstetric care units. As it is part of standard delivery-room protocols, it ensures consistent institutional procurement and reliable turnover.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in gynecology, obstetric emergency, and hospital injectable segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from regular hospital demand, delivery room usage, and emergency obstetric protocols, making it a stable and essential pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in gynecology and obstetric injectable products can contact Cafoli Lifecare to discuss hospital supply requirements, pricing, and PCD pharma franchise opportunities in the maternity and critical-care segment.